Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma

This publication has 38 references indexed in Scilit:

• Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication
  Carcinogenesis: Integrative Cancer Research, 2009
• Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer
  Journal of Clinical Oncology, 2005
• Cell cycle, proteolysis and cancer
  Current Opinion in Cell Biology, 2004
• Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry
  Nature, 2004
• X-Tile
  Clinical Cancer Research, 2004
• Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin
  Oncogene, 2004
• Themes and variations on ubiquitylation
  Nature Reviews Molecular Cell Biology, 2001
• Cell cycle regulation by the ubiquitin pathway
  The FASEB Journal, 1997
• Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase
  Proceedings of the National Academy of Sciences, 1997
• ESTROGEN-RECEPTOR ANALYSES - CORRELATION OF BIOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS USING MONOCLONAL ANTIRECEPTOR ANTIBODIES
  1985